semaglutide patent expiration 2031 Off-patent in 2026: the next revolution in anti-obesity medications In weight loss battle, Novo

Losing 20 to 30 pounds on GLP-1 medications doesnt replace exercise, nutrition, sleep, and other healthy lifestyle changes

Key finding: Unprecedented mitochondria-to-nucleus communication pathway for metabolic adaptation

Tirzepatide, semaglutide, liraglutide, and, to a lesser extent, naltrexonebupropion provided significant improvement in glycemic parameters and variable rates of type 2 diabetes remission 6 (Table 1)

Nicholls SJ, Bhatt DL, Buse JB et al (2023) Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics

Lavin wasnt involved in the study

If you are healthy, your body makes what it needsprovided you feed it protein and get adequate sleep